📣GenomeWeb: Positioning the Idylla™ System for Sample-to-Answer Oncology CDx Tests 👉Read the article: genomeweb.com/.../biocartis-…... 👉 Discover the Idylla™ CDx MSI Test: biocartis.com/.../idylla.../…

🎗️October is Breast Cancer Awareness Month, a month to raise awareness about breast cancer. Awareness is the first step in the battle against cancer ❤️ Discover our Breast Cancer Assay Portfolio* biocartis.com/en/breast-canc… *For Research Use Only, not for use in diagnostic procedures

𝗝𝗢𝗜𝗡 𝗢𝗨𝗥 𝗙𝗥𝗘𝗘 𝗪𝗘𝗕𝗜𝗡𝗔𝗥: 𝗜𝗱𝘆𝗹𝗹𝗮™ 𝗶𝗻 𝗰𝘆𝘁𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝘀𝗮𝗺𝗽𝗹𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 📅 Tuesday 7 October, 11:00 AM (CET) 🗣️ Spanish 👉 Save your spot: register.gotowebinar.com/#register/7668…

💡 Let's start innovating together! Biocartis’ mission is to ensure patients and their physicians have access to the right test results at the right time to deliver the right treatment. Contact our pharma partnering team 👉 biocartis.com/en/partnering/…

JOIN OUR FREE WEBINAR: Unlocking POLE Testing in Endometrial Cancer: Guideline-Based Molecular Classification 📅 Wednesday 29 October, 3:00 PM (CET) 🗣️Italian 👉Save your spot: register.gotowebinar.com/register/70701…

🚀COMING SOON: Idylla™ PIK3CA-AKT1 Mutation Assay - 13 PIK3CA and 1 AKT1 mutations in single cartridge - Fully automated results in ~150 min - Suitable for small biopsies, 1 FFPE tissue section biocartis.com/en/research/re… For Research Use Only, not for use in diagnostic procedures

Mark your calendars for AMP! 🗓️ 11-15 Nov |🗺️ Boston, MA, US |📍Booth 421 Don't miss our AMP workshop: Fast EGFR Testing in Cytopathology: A Practical Implementation Experience, hosted by Dr. Roberto Ruiz-Cordero 🗓️ 12 Nov, 03:00 PM (EST) | 📍 156AB, level 1

Idylla™ POLE-POLD1 Mutation Assay* ✅ Molecular classification of #EndometrialCancer samples in ~95 min ✅ Covers 99% of the known pathogenic #POLE & #POLD1 mutations biocartis.com/en/research/re… *For Research Use Only (RUO), not for use in diagnostic procedures

🎗️October is Breast Cancer Awareness Month, a month to raise awareness about breast cancer. Awareness is the first step in the battle against cancer❤️ Discover our Breast Cancer Assay Portfolio* biocartis.com/en/breast-canc… *For Research Use Only, not for use in diagnostic procedures

💡 Join our AMP workshop: Fast EGFR* Testing in Cytopathology: A Practical Implementation Experience 🗣️ Dr. Roberto Ruiz-Cordero (University of Miami) 🗓️ 12 Nov, 03:00 PM (EST) 📍 156AB, level 1 *For Research Use Only, not for use in diagnostic procedures

Molecular biomarker results in ONLY 3 HOURS 🔬 💡 THINK IDYLLA™ Today, Biocartis offers tests supporting lung, skin, thyroid, colorectal, endometrial, blood, brain and breast cancer. More information 👉 biocartis.com/en/meet-idylla… #Biocartis #Idylla #ThinkIdylla

JOIN OUR FREE WEBINAR: Unlocking POLE Testing in Endometrial Cancer: Guideline-Based Molecular Classification 📅 Wednesday 29 October, 3:00 PM (CET) 🗣️Italian 👉Save your spot: register.gotowebinar.com/register/70701…

🎗️ This Breast Cancer Awareness Month, we’re turning the spotlight on our Breast Cancer Assay Portfolio* 👉 Learn more here: biocartis.com/en/breast-canc… *For Research Use Only (RUO), not for use in diagnostic procedures. Kits are developed by APIS, distributed by Biocartis.

Mark your calendars for AMP! 🗓️ 11-15 Nov | 📍Boston, MA, US biocartis.com/en-US/news-eve… Don't miss our AMP workshop: Fast EGFR Testing in Cytopathology: A Practical Implementation Experience, hosted by Dr. Roberto Ruiz-Cordero 🗓️ 12 Nov, 03:00 PM (EST) | 📍 156AB, level 1

Next week we are attending Precision Oncology & Diagnostics 2025 Conference! 📅 5-6 November | 🗺️ New York, NY, US Stop by and learn more about getting molecular biomarker results in ⏱️only 3 hours⏱️ with Idylla™! 👉 Book your meeting: lnkd.in/eRxYe3YF

Revolutionize your NSCLC diagnostics with Idylla™ 🏆 Test for EGFR, ALK, ROS1, RET & METex14 in ONLY 3 HOURS and immediately start the right targeted therapy for >90% of your patients with first-line actionable biomarkers*. 👉🏻biocartis.com/sites/default/… *biocartis.com/en/reference-h…

🎃 Trick or treat? This Halloween, we’re skipping the tricks and going straight to the treats. 🍬 Our treat: Molecular biomarker results in only 3 hours with Idylla™ biocartis.com/en/meet-idylla… Happy Halloween from all of us at Biocartis! 👻🧬 #Idylla #Biocartis #Halloween

November is Lung Cancer Awareness Month🫁 💡Did you know that lung cancer is the most common type of cancer? Idylla™ allows for fast & accurate results of key NSCLC gene mutations in ONLY 3 HOURS, speeding up therapy decisions for better patient outcomes biocartis.com/en/idylla-for-…

📢 NOW AVAILABLE: Idylla™ CDx MSI Test For the identification of MSI-H CRC patients who may benefit from treatment with OPDIVO® ± YERVOY® 👉 biocartis.com/en-US/meet-idy… Approved in the US under P250005. OPDIVO® and YERVOY® are registered trademarks of Bristol-Myers Squibb Company

💡 Join our AMP workshop: Fast EGFR* Testing in Cytopathology: A Practical Implementation Experience 🗣️Dr. Roberto Ruiz-Cordero (University of Miami) 📅12 Nov, 03:00 PM (EST) 📍 156AB, level 1 *For Research Use Only, not for use in diagnostic procedures